 ImprimisRx, the nations leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow Health, Inc. HROW, today announced its Klarity-C preservative-free formulation 0.1 cyclosporine emulsion may now be prescribed by Floridas nearly 2,000 optometrists1 as a result of the Florida Board of Optometrys recent additions to its Formulary of Topical Ocular Pharmaceutical Agents. Klarity-C, which is produced according to the highest federal manufacturing standards at the ImprimisRx FDA-registered outsourcing facility, has been one of ImprimisRxs fastest growing topical formulations. 